Experiment 444612

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

TRIPTOGELIN A-1

Details

PropertyValue
Pharmacology
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
OrganismEmpty organism
CitationUJITA,K: TAKAISHI,Y: TOKUDA,H: NISHINO,H: IWASHIMA,A: FUJITA,T:. (1993). INHIBITORY EFFECTS OF TRIPTOGELIN A-1 ON 12-O-TETRRADECANOYLPHORBOL-13-ACETATE-INDCUED SKIN TUMOR PROMOTION.. 68(2/3)
Amount utilized
Compound isolated
DiseaseVS.12-O-TETRADECANOYLPHORBOL-13-ACETATE INDUCED EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION.
Dose amount85.0 NANOMOLS
Number1
Qualitative resultACTIVE
AnimalCELL CULTURE
Dose expressionCONC USED